$11.33
-0.61-5.11%
At close: -
$11.33
0.000.00%
After Hours: 4:00 PM EDT
Comments
Loading...
Entrada Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:TRDA | Benzinga
Entrada Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$-0.720
Quarterly Revenue Estimate
$11.95M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$210.78M
Analyze the earnings history of Entrada Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Entrada Therapeutics (TRDA) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $0.03 | $-0.66 | 104.6 % |
| Q3 | 2024-11-05 | $-0.35 | $-0.73 | 52.0 % |
| Q2 | 2024-08-13 | $1.55 | $0.14 | 1007.1 % |
| Q1 | 2024-05-07 | $0.68 | $-0.59 | 215.3 % |
Entrada Therapeutics (TRDA) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $37.40M | $12.92M | 189.5 % |
| Q3 | 2024-11-05 | $19.57M | $12.32M | 58.9 % |
| Q2 | 2024-08-13 | $94.69M | $46.07M | 105.5 % |
| Q1 | 2024-05-07 | $59.12M | $14.98M | 294.7 % |
FAQ
When is Entrada Therapeutics (NASDAQ:TRDA) reporting earnings?
Entrada Therapeutics (TRDA) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on February 27, 2025 for Q4.
What were the latest earnings per share (EPS) for Entrada Therapeutics (NASDAQ:TRDA)?
The Actual EPS was $0.03, which beat the estimate of $-0.66.
What were Entrada Therapeutics’s (NASDAQ:TRDA) revenues?
The Actual Revenue was $37.4M, which beat the estimate of $12.9M.
Browse earnings estimates, EPS, and revenue on all stocks.